Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Several key aspects differentiate our library:
partner
Reaxense
upacc
P21128
UPID:
ENDOU_HUMAN
Alternative names:
Placental protein 11; Protein endoU
Alternative UPACC:
P21128; B2RBJ3; B3KQS7; B7Z6E1; Q2NKJ4
Background:
Uridylate-specific endoribonuclease, also known as Placental protein 11 or Protein endoU, is a pivotal enzyme that specializes in cleaving single-stranded RNAs. It targets uridylates, favoring UU and GU sites over CU and AU, to release products with a 2',3'-cyclic phosphate at the 3'-end. This specificity underscores its unique role in RNA metabolism.
Therapeutic significance:
Understanding the role of Uridylate-specific endoribonuclease could open doors to potential therapeutic strategies. Its precise function in RNA processing not only highlights its importance in cellular biology but also suggests avenues for drug discovery targeting RNA-related diseases.